IGC Pharma, Inc. (IGC)
IGC Stock Price Chart
Explore IGC Pharma, Inc. interactive price chart. Choose custom timeframes to analyze IGC price movements and trends.
IGC Company Profile
Discover essential business fundamentals and corporate details for IGC Pharma, Inc. (IGC) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
24 May 2006
Employees
67.00
Website
https://igcpharma.comCEO
Ram Mukunda
Description
IGC Pharma, Inc. is a clinical-stage pharmaceutical company that is focused on Alzheimer's disease, developing innovative solutions to address this devastating illness. It has two investigational drug assets targeting Alzheimer's disease: IGC-AD1, which is in a Phase 2 clinical trial as a treatment for agitation in dementia due to Alzheimer's and TGR-63 that is in pre-clinical development. In addition to its drug development pipeline, IGC Pharma seeks to leverage artificial intelligence (AI) for Alzheimer's research. The company was founded by Ram Mukunda on April 29, 2005 and is headquartered in Potomac, MD.
IGC Financial Timeline
Browse a chronological timeline of IGC Pharma, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 12 Feb 2026
Upcoming earnings on 11 Nov 2025
EPS estimate is -$0.03.
Earnings released on 14 Aug 2025
EPS came in at -$0.02 surpassing the estimated -$0.03 by +33.33%.
Earnings released on 27 Jun 2025
EPS came in at -$0.01 surpassing the estimated -$0.02 by +50.00%, while revenue for the quarter reached $330.00K , beating expectations by +8.20%.
Earnings released on 14 Feb 2025
EPS came in at -$0.02 surpassing the estimated -$0.03 by +33.33%, while revenue for the quarter reached $257.00K , missing expectations by -12.88%.
Earnings released on 12 Nov 2024
EPS came in at -$0.02 falling short of the estimated -$0.02 by -23.08%, while revenue for the quarter reached $412.00K , beating expectations by +37.33%.
Earnings released on 8 Aug 2024
EPS came in at -$0.03 falling short of the estimated -$0.03 by -15.92%, while revenue for the quarter reached $272.00K , meeting expectations.
Earnings released on 24 Jun 2024
EPS came in at -$0.04 falling short of the estimated -$0.00 by -900.00%, while revenue for the quarter reached $295.00K , beating expectations by +55.26%.
Earnings released on 14 Feb 2024
EPS came in at -$0.09 falling short of the estimated -$0.04 by -125.00%, while revenue for the quarter reached $204.00K , beating expectations by +7.37%.
Earnings released on 9 Nov 2023
EPS came in at -$0.05 , while revenue for the quarter reached $291.00K .
Earnings released on 7 Jul 2023
EPS came in at -$0.08 , while revenue for the quarter reached $555.00K .
Earnings released on 30 Jun 2023
EPS came in at -$0.13 , while revenue for the quarter reached $166.00K .
Earnings released on 14 Feb 2023
EPS came in at -$0.04 , while revenue for the quarter reached $332.00K .
Earnings released on 1 Nov 2022
EPS came in at -$0.05 , while revenue for the quarter reached $202.00K .
Earnings released on 8 Aug 2022
EPS came in at -$0.05 , while revenue for the quarter reached $212.00K .
Earnings released on 22 Jun 2022
EPS came in at -$0.13 , while revenue for the quarter reached $122.00K .
Earnings released on 10 Feb 2022
EPS came in at -$0.05 , while revenue for the quarter reached $142.00K .
Earnings released on 29 Oct 2021
EPS came in at -$0.09 , while revenue for the quarter reached $56.00K .
Earnings released on 11 Aug 2021
EPS came in at -$0.04 , while revenue for the quarter reached $77.00K .
Earnings released on 14 Jun 2021
EPS came in at -$0.07 , while revenue for the quarter reached $81.00K .
Earnings released on 12 Feb 2021
EPS came in at -$0.06 , while revenue for the quarter reached $108.00K .
Earnings released on 20 Nov 2020
EPS came in at -$0.04 , while revenue for the quarter reached $125.00K .
IGC Stock Performance
Access detailed IGC performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.